Agenda

Sessions:

Thursday, July 14

11:00-12:15 pm

Check-In & Registration

12:15-1:20 pm

Buffet Lunch

 12:20-1:20 pm

Industry Supported Lecture
Presented by Novartis Pharmaceuticals
*Not eligible for CME Credit

1:20-1:40 pm

Check-In, Break, and Exhibits

1:40-1:45 pm

Introduction and Program Overview
Kirkwood F. Adams, Jr., MD

Session I: Current Approaches to the Management of Heart Failure
Moderator: J. Herbert Patterson, PharmD

1:45-2:10 pm

“Old School” But Still Essential Drug Therapies for Heart Failure
Stephanie H. Dunlap, DO

2:10-3:05 pm

Optimizing Polypharmacy – Latest Strategies to Resolve Treatment Gaps in HFrEF
Moderators: Kirkwood F. Adams, Jr, MD and J. Herbert Patterson, PharmD
Speaker:
Nancy M. Albert, PhD, RN
Panelists: Javed Butler, MD, MPH, MBA, Marvin Konstam, MD, and Alan B. Miller, MD

3:05-3:20 pm

Break & Exhibits

3:20-3:45 pm

Clinical Challenges: Therapeutic Concepts in Heart Failure with Preserved EF
Marvin A. Konstam, MD

3:45-4:10 pm

Optimizing Treatment of HFpEF: Role of Polypharmacy
Robert J. Mentz, MD and Javed Butler, MD, MPH, MBA

4:10-4:45 pm

Bench to Bedside in HFpEF: Pathophysiological Mechanisms and Clinical Phenotypes
Moderator: Robert J. Mentz, MD
Panelists: Marvin A. Konstam, MD and Javed Butler, MD, MPH, MBA

4:45-5:30 pm

Making Polypharmacy Work in the Clinic – Case Vignettes with Discussion
Case Presenters: Douglas D. Schocken, MD
Case Discussants: Nancy M. Albert, PhD, RN, Stephanie H. Dunlap, DO, Robert L. Page II, PharmD, Sara Paul, DNP, and Hector O. Ventura, MD

Friday, July 15

7:30-8:00 am

Breakfast, Check-In & Exhibits

Session II: Electrophysiological Approaches to Heart Failure
Moderator: Alan B. Miller, MD

8:00-8:25 am

Electrophysiologist’s Perspective: How Can Implantable Cardiac Rhythm Management Devices Help My Heart Failure Patients?
Anil K. Gehi, MD

8:25-8:40 am

EP Panel Discussion
Discussants:  Alan B. Miller, MD, Anil K. Gehi, MD, and Matthew Baker, MD

Session III: Latest on Surgical and Device Strategies for Advanced Heart Failure
Moderator: Patricia P. Chang, MD, MHS

8:40-9:05 am

Ventricular Assist Devices: Latest Strategies for Optimal Clinical Application
Mirnela Byku, MD, PhD, MBA

9:05-9:30 am

Mitral Regurgitation: Causes, Natural History, Classic and Novel Interventions
JoAnn Lindenfeld, MD

9:30-9:45 am

Break & Exhibits

9:45 -10:10 am

Real World Insights on Cardiac Assist Devices and Transplantation
James B. Young, MD

10:10-10:50 am

Surgical Approaches to Advanced Heart Failure: Patient Selection and Timing
Moderator: Patricia P. Chang, MD, MHS
Case Presenter: Sudha Jaganathan, MD
Panelists: James B. Young, MD, Christopher V. Chien, MD, and William T. Abraham, MD

10:50-11:45 am

Featured Panel Discussion:  Advanced Heart Failure: Latest on Clinical Application of Mechanical Circulatory Support and Left Ventricular Assist Device Therapy
Moderator: Patricia P. Chang, MD, MHS 
Speakers: David Lanfear, MD and Paul B. Tessmann, MD, PharmD
Commentary: William T. Abraham, MD and Mirnela Byku, MD, PhD, MBA

Hot Topic Update on Novel and Investigational Devices for Heart Failure

11:40-12:20 pm

Expert Panel Discussion: Novel and Investigational Devices for Monitoring and Treatment of CHF
Moderator: Kirkwood F. Adams, Jr., MD
Speakers: Christopher V. Chien, MD, Alan B. Miller, MD, Marvin A. Konstam, MD, and William T. Abraham, MD
Panel Discussion: JoAnn Lindenfeld, MD


Satellite Breakout Luncheon Session

12:30-1:30 pm

CME Credit provided by VoxMedia
Supported by an independent educational grant from Cytokinetics Incorporated
Lunch and Featured Panel Discussion: Turning the Tide on Outcomes in Worsening Heart Failure in Patients with Reduced Ejection Fraction
Speaker: Robert Mentz, MD
Panelists: Nancy M. Albert, PhD, RN, Javed Butler, MD, MPH, MBA, and David Lanfear, MD


1:30-2:30 pm

Concurrent Workshops

Nursing Challenges in Caring for the Chronic Heart Failure Patient
Jana M. Glotzer, MSN, ACNP, Sarah Waters, ANP-BC, Carrie Neal, RN, BSN, and Tammy Long, AGNP

Optimizing Patient Selection for EP Device and Intervention Therapy
Anil K. Gehi, MD and Matthew Baker, MD

Clinical Application of Biomarkers and Omics in Day to Day Heart Failure Patient Care
Kirkwood F. Adams, Jr., MD, Ileana L. Piña, MD, MPH, and David E. Lanfear, MD

Case-Based Interactive Discussion: How to Do an Effective Heart Failure History and Physical
Douglas D. Schocken, MD

Cardio-Oncology: Clinical Case Discussions
Jo Ellen Rodgers, PharmD and Katherine Di Palo, PharmD

Saturday, July 16

7:15-8:30 am

Breakfast, Check-In & Exhibits

7:00-8:00 am

Industry Supported Lecture: TLO: Treatment Considerations for Patients with HFrEF and Select Updates From the 2022 HF Guideline
Jason Feliberti, MD
Presented by Merck
*Not eligible for CME Credit

Session IV: Future Directions in Heart Failure Therapy: Biomarkers, Cardiomyopathy, and Late Breaking Trials
Moderator: Kirkwood F. Adams, Jr., MD

8:30-8:55 am

Personalizing Medicine in Heart Failure – Revisiting the Role of Genomics
David E. Lanfear, MD

8:55-9:20 am

Omics and Latest Insights Into the Pathophysiology of Heart Failure
Peter P. Liu, MD

9:20-9:30 am

Q&A/Panel Discussion

9:30-10:00 am

Advances in Diagnosis and Treatment of Cardiac Amyloid: Key Role of Novel Drug Therapy
Mathew S. Maurer, MD

10:00-10:10 am

Clinical Discussion of Nuances in the Management of Cardiac Amyloid
Mathew S. Maurer, MD and Alan B. Miller, MD

10:10-10:35 am

Myosin Modulation: Mavacamten in Obstructive Hypertrophic Cardiomyopathy
Anjali Owens, MD

10:35-10:50 am

Break & Exhibits

10:50-11:15 am

Guanylate Cyclase Stimulation-Vericiguat: Insights VICTORIA and VITALITY-HFpEF Trials
Javed Butler, MD, MPH

11:15-11:40 am

Myosin Modulation: Update on Omecamtiv Mecarbil in HFrEF: Latest Galactic-HF Results
Kirkwood F. Adams, Jr., MD

11:40-12:05 pm

Latest Approaches with SGLT2 Inhibitors to Improve CV Outcomes in HFrEF and HFpEF
Ileana L. Piña, MD, MPH

12:05-12:30 pm

Update on Novel Therapeutic Approaches to Heart Failure
Kirkwood F. Adams, Jr., MD

12:40-1:30 pm

Breakout Luncheon – Featured Panel

Expert Panel Discussion:  Potential Opportunities and Challenges for Novel Therapies as Components of the Polypharmacy of Heart Failure: Latest Clinical Perspectives
Moderator: Kirkwood F. Adams, Jr., MD
Panelists: Ileana L. Piña, MD, MPH, David E. Lanfear, MD, Robert J. Mentz, MD, and Javed Butler, MD, MPH

1:30-2:30 pm

Concurrent Workshops

Pharmacotherapeutic Challenges in Treating the Heart Failure Patient
Robert L. Page II, PharmD, Barry E. Bleske, PharmD, and Zachary L. Cox, PharmD

Advanced and Refractory HF: Individualizing LVAD and Hemodynamic Monitoring Strategies
Robert T. Cole, MD, Sudha Jaganathan, MD, Lauren B. Cooper, MD, Evan Hiner, MD, and Megan Andrews, MSN, APRN, ANP-C

Unusual Cardiomyopathies: Approaches to Evaluation and Management
Mirnela Byku, MD, PhD, MBA, Mathew S. Maurer, MD, Uri Elkayam, MD, and Kirkwood F. Adams, Jr., MD

Optimizing Therapy in HF Patients with Sleep Disordered Breathing
William G. Cotts, MD

Cardiac Contractility Modulation Therapy for Heart Failure
Faisal F. Syed, BSc, MBChB

Sunday, July 17

7:30-8:00 am

Continental Breakfast, Check-In & Exhibits

Session V: Clinical Science to Clinical Care – Making it Happen in the CHF Clinic
Moderator: Kirkwood F. Adams, Jr., MD

8:00-8:35 am

Optimizing Care in Heart Failure – Process Matters
Ileana L. Piña, MD, MPH

8:35-9:25 am

The Team Approach to Heart Failure Patient Management
Moderator: Ileana L. Piña, MD, MPH
Panel Discussion: Tammy Long, AGNP, Jana M. Glotzer, MSN, ACNP, and Katherine Di Palo, PharmD

9:25-9:50 am

Advancing the Cardiovascular Care of the Oncology Patient
Jo Ellen Rodgers, PharmD

9:50-10:20 am

Pulmonary Arterial Hypertension: Latest Concepts in Evaluation and Treatment
Lisa J. Rose-Jones, MD

10:20-10:50 am

Atrial Fibrillation: Consequences and Therapeutic Implications in CHF
Anil K. Gehi, MD

10:50-11:10 am

Current Clinical Approaches to Important Co-morbidities in Heart Failure
Moderator: Kirkwood F. Adams, Jr., MD
Panel Discussion:
Lisa J. Rose-Jones, MD, Anil K. Gehi, MD, and Jo Ellen Rodgers, PharmD

11:10-12:00 pm

Clinical Conundrums: Decision Making in Challenging CHF Cases
Moderator: Hector O. Ventura, MD
Panelists: Ileana L. Piña, MD, MPH and Kirkwood F. Adams, Jr., MD

12:00 pm

ADJOURN